×
About 10,815 results

ALLMedicine™ Hepatitis B Virus Center

Research & Reviews  4,136 results

Effect of tenofovir-based HIV pre-exposure prophylaxis against HBV infection in men who...
https://doi.org/10.1097/HEP.0000000000000384
Hepatology (Baltimore, Md.); Mizushima D, Takano M et. al.

Mar 25th, 2023 - Men who have sex with men (MSM) are vulnerable to contracting hepatitis B virus (HBV) as a sexually transmitted infection (STI). We evaluated the incidence of HBV infection (HBI) and the prophylactic effect of tenofovir-based pre-exposure prophyla...

Characteristics, treatment and care of pregnant women living with hepatitis B in Englan...
https://doi.org/10.1017/S0950268823000225
Epidemiology and Infection; Bailey H, Nastouli E et. al.

Mar 25th, 2023 - Around 0.4% of pregnant women in England have chronic hepatitis B virus (HBV) infection and need services to prevent vertical transmission. In this national audit, sociodemographic, clinical and laboratory information was requested from all matern...

Two fragments of HBV DNA integrated into chrX: 11009033 and its genetic regulation in H...
https://doi.org/10.3892/mmr.2023.12985
Molecular Medicine Reports; Ruan P, Zhou R et. al.

Mar 25th, 2023 - Hepatitis B virus (HBV) integration into human genome causes hepatocellular carcinoma (HCC). The present study used inverse nested PCR; the full sequence of HBV DNA fragments of the chrX: 111009033 integration site was detected (987 bp), containin...

Structural conservation of HBV-like capsid proteins over hundreds of millions of years ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10033635
Nature Communications; Pfister S, Rabl J et. al.

Mar 24th, 2023 - The discovery of nackednaviruses provided new insight into the evolutionary history of the hepatitis B virus (HBV): The common ancestor of HBV and nackednaviruses was non-enveloped and while HBV acquired an envelope during evolution, nackednavirus...

Humoral responses after primary and booster SARS-CoV-2 inactivated vaccination in patie...
https://doi.org/10.1002/jmv.28695
Journal of Medical Virology; Chen Z, Huang T et. al.

Mar 23rd, 2023 - Given the pandemic of severe acute respiratory syndrome coronavirus 2 Omicron variants, booster vaccination (BV) using inactivated virus vaccines (the third dose) has been implemented in China. However, the immune responses after BV, especially th...

see more →

Guidelines  7 results

Universal Hepatitis B Vaccination in Adults Aged 19-59 Years: Updated Recommendations o...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979596
MMWR. Morbidity and Mortality Weekly Report; Weng MK, Doshani M et. al.

Apr 1st, 2022 - Hepatitis B (HepB) vaccines have demonstrated safety, immunogenicity, and efficacy during the past 4 decades (1,2). However, vaccination coverage among adults has been suboptimal, limiting further reduction in hepatitis B virus (HBV) infections in...

Non-invasive diagnosis and follow-up of chronic infection with hepatitis B virus.
https://doi.org/10.1016/j.clinre.2021.101773
Clinics and Research in Hepatology and Gastroenterology; Leroy V, Chevaliez S et. al.

Aug 1st, 2021 - Diagnosis of chronic hepatitis B virus (HBV) infection, initial staging of infection and monitoring of treated and untreated patients are mainly based on clinical, biological and imaging criteria allowing a complete non-invasive management for the...

Hepatitis B Virus Screening and Management for Patients With Cancer Prior to Therapy: A...
https://doi.org/10.1200/JCO.20.01757
Journal of Clinical Oncology : Official Journal of the Am... Hwang JP, Feld JJ et. al.

Jul 28th, 2020 - This Provisional Clinical Opinion update presents a clinically pragmatic approach to hepatitis B virus (HBV) screening and management. All patients anticipating systemic anticancer therapy should be tested for HBV by 3 tests-hepatitis B surface an...

Management of hepatitis B virus infection, updated Swedish guidelines.
https://doi.org/10.1080/23744235.2019.1675903
Infectious Diseases (London, England); Westin J, Aleman S et. al.

Oct 16th, 2019 - Despite access to effective antiviral drugs and vaccines, hepatitis B virus (HBV) infection remains a major health issue worldwide. HBV is highly infectious and may cause chronic infection, progressive liver damage, hepatocellular cancer (HCC) and...

Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5837403
MMWR. Recommendations and Reports : Morbidity and Mortali... Schillie S, Vellozzi C et. al.

Jun 26th, 2018 - HEPATITIS B VIRUS (HBV) IS TRANSMITTED VIA BLOOD OR SEXUAL CONTACT. PERSONS WITH CHRONIC HBV INFECTION ARE AT INCREASED RISK FOR CIRRHOSIS AND LIVER CANCER AND REQUIRE MEDICAL CARE. THIS REPORT UPDATES AND SUMMARIZES PREVIOUSLY PUBLISHED RECOMMEND...

see more →

Drugs  13 results see all →

News  170 results

Bepirovirsen: Is a 'Functional Cure' for HBV on the Horizon?
https://www.medscape.com/viewarticle/984213

Nov 17th, 2022 - Treatment with bepirovirsen led to sustained clearance of hepatitis B surface antigen (HBsAg) and hepatitis B virus (HBV) DNA for 24 weeks after the end of treatment for adults with chronic HBV in the phase 2b B-Clear study. The study results were...

World Falls Short on HBV, HCV Elimination Targets
https://www.medscape.com/viewarticle/983719

Nov 8th, 2022 - Vaccination campaigns in more than 80 nations have successfully reduced the prevalence of hepatitis B virus (HBV) surface antigen. That’s the good news. Less good is the news that no countries are on track to meet the goals for HBV eradication by ...

FDA Expands Tenofovir Alafenamide (Vemlidy ) Use to Adolescents With Chronic HBV
https://www.medscape.com/viewarticle/983596

Nov 4th, 2022 - The US Food and Drug Administration (FDA) has expanded the indication for tenofovir alafenamide (Vemlidy) to children aged 12 years and older with chronic hepatitis B virus (HBV) infection with compensated liver disease, Gilead Sciences has announ...

Antiviral Therapy Improves Survival After Liver Cancer Surgery
https://www.medscape.com/viewarticle/982766

Oct 20th, 2022 - The study covered in this summary was published on researchsquare.com as a preprint and has not yet been peer reviewed. Key Takeaway Antiviral therapy improves survival among elderly patients after hepatectomy for hepatitis B virus (HBV)–related h...

CDC Says More Is Needed to Protect Infants From Hepatitis B
https://www.medscape.com/viewarticle/979110

Aug 11th, 2022 - Progress has occurred in reducing maternal-to-child transmission of hepatitis B but is still lagging, particularly in Africa, according to a recent report from the Centers for Disease Control and Prevention (CDC) on maternal-to-child transmission ...

see more →